Personal Diabetes Product Experience
IME-9 Review: My Blood Sugar Readings, Reported Side Effects and Experience
This is a first-person account of using one bottle of IME-9 for 28 days while continuing prescribed diabetes medicine and regular exercise. It records the author's fasting glucose readings and symptoms experienced during that period. It does not establish that IME-9 caused either the glucose changes or the reported symptoms, and it should not be treated as medical advice.
How I Used IME-9
I used one bottle of IME-9 for 28 days together with my regular diabetes medicine, Gemer-2. At that time my stated routine was one Gemer-2 tablet in the morning and one in the evening, together with two IME-9 tablets. I was also running approximately 2 km every day and doing regular exercise for about 45 minutes.
Because several things were happening at the same time-prescription medicine, IME-9, running and other exercise-the observations below cannot establish which factor was responsible for a change in my glucose readings.
Fasting Blood Glucose Readings During My IME-9 Trial
| Stage | Reported fasting blood glucose |
|---|---|
| Before taking IME-9 | 146 mg/dL |
| After the second week | 125 mg/dL |
| After the third week | 114 mg/dL |
My fasting glucose readings fell during this period. However, IME-9 was being used together with my regular diabetes medicine and substantial daily exercise. These numbers therefore do not prove that IME-9 itself produced the reduction.
Symptoms I Experienced While Using IME-9
During the period in which I used the product, I experienced several symptoms that concerned me. I describe them below as reported experiences. The timing does not establish that IME-9 caused them.
- 1. Itching and skin changes I noticed itching and other symptoms that I considered to be a skin allergy from an early stage. By the time I had completed 56 tablets, I also noticed small wounds or lesions on both legs. I had experienced a similar problem during an earlier period when I used BGR-34.
- 2. Dry skin My skin became unusually dry during this period. I expected it would take time to return to its previous condition.
- 3. Tiredness and physical weakness I felt unusually tired and sleepy while using the product. After returning to my earlier treatment routine, I felt more able to run and exercise normally.
Anyone who develops a rash, wounds, marked fatigue or other concerning symptoms while taking a medicine or supplement should obtain appropriate medical advice. Symptoms in a person with diabetes can have several possible causes and should not automatically be attributed to one product.
Why I Did Not Use IME-9 Alone
A few months earlier I had stopped my regular medicine while trying BGR-34. I later regarded that decision as a mistake. Before that trial, my fasting glucose was generally below 135 mg/dL according to my records; after one bottle of BGR-34 I recorded a fasting value of 167 mg/dL.
That earlier experience was the reason I did not discontinue my prescribed diabetes medicine when I tried IME-9. It also reinforced an important point: a diabetes patient should not use an online advertisement or testimonial as a reason to stop prescribed treatment.
Can IME-9 Cure Diabetes or Replace Regular Medicine?
My experience cannot establish that IME-9 cures diabetes, and I do not recommend using this personal review as evidence that prescribed treatment can be stopped. During my IME-9 trial I continued my regular medicine and exercise, so even the fall in my fasting readings cannot be attributed to IME-9 alone.
Diabetes management should be based on appropriate medical review, blood-glucose monitoring, HbA1c where advised, diet, physical activity and medication decisions made for the individual patient.
Are Ayurvedic or Herbal Medicines Free From Side Effects?
A product being described as Ayurvedic, herbal or natural does not establish that it is incapable of producing an unwanted effect or interacting with another treatment. At the same time, symptoms experienced by one person do not prove that a particular product caused them or that every user will experience the same problem.
If a complementary product is used alongside glucose-lowering medicine, the treating healthcare professional should be informed so that blood glucose and possible interactions or adverse effects can be assessed appropriately.
My Recommendation
IME-9 may produce a different experience in another person, but I would not rely blindly on advertisements or testimonials. My own glucose readings improved during the 28-day period, but I was simultaneously taking my prescribed medicine and exercising regularly, so I cannot say that IME-9 was responsible.
I also experienced skin symptoms, dry skin and significant tiredness during the same period. I therefore consider professional medical advice and objective glucose monitoring more important than promotional claims when deciding whether to use any complementary diabetes product.
Health and Diabetes Advertising: Applicable Indian Law
Health-related advertisements in India are subject to consumer-protection and drug-advertising law. The Consumer Protection Act, 2019 provides a framework for action against false or misleading advertisements through the Central Consumer Protection Authority. The CCPA's Guidelines for Prevention of Misleading Advertisements and Endorsements for Misleading Advertisements, 2022 establish further standards for advertisements and endorsements.
Advertisements concerning drugs and remedies may also be governed by the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. Section 3 restricts advertisements of certain drugs for treatment of specified diseases and disorders, while Section 4 prohibits misleading advertisements relating to drugs. These provisions are stated here as general legal context and not as a finding that any particular product or advertisement violates the law.
Official Resources
- Indian Council of Medical Research - Official Guidelines
- ICMR Guidelines for Management of Type 2 Diabetes
- Department of Consumer Affairs - Consumer Protection Act, 2019 and related rules/guidelines
- CCPA Guidelines for Prevention of Misleading Advertisements and Endorsements, 2022
- India Code - Drugs and Magic Remedies (Objectionable Advertisement) Act, 1954
Author note: The author's identity may be disclosed on genuine request, subject to privacy considerations.